Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Leukemia 32Leukemia, Myeloid, Acute 20Lymphoma 19Lymphoma, Follicular 18Breast Neoplasms 18Congenital Abnormalities 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 13Carcinoma, Non-Small-Cell Lung 13Hodgkin Disease 12Head and Neck Neoplasms 12Burkitt Lymphoma 12Lymphoma, Non-Hodgkin 11Colonic Neoplasms 11Multiple Myeloma 10Lung Neoplasms 10Leukemia, Myeloid, Chronic-Phase 10Squamous Cell Carcinoma of Head and Neck 9Rectal Neoplasms 9Neuroblastoma 9Melanoma 9Lymphoma, T-Cell, Cutaneous 9Colorectal Neoplasms 9Sezary Syndrome 8Sarcoma 8Myeloproliferative Disorders 8

Interventions

Gemcitabine 95Cisplatin 72Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 13tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Polymerase Chain Reaction × Clear all
NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

Peking Union Medical College Hospital

Unknown
450 enrolled
GastrointestinalOther neoplasm

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡